Functional classification of left ventricular remodelling: prognostic relevance in myocardial infarction

Surenjav Chimed1, Pieter van der Bijl1, Rodolfo Lustosa1

  • 1Department of Cardiology, Heart and Lung Centre, Leiden University Medical Centre, Albinusdreef 2, Leiden, 2300 RC, The Netherlands.

ESC Heart Failure
|January 22, 2022
PubMed

Insights

This study reclassified left ventricular (LV) remodelling after ST-segment elevation myocardial infarction (STEMI) by including LV function. Patients with LV remodelling and impaired ejection fraction (EF) had significantly worse outcomes, improving risk stratification.

Area of Science:

  • Cardiology
  • Clinical Research
  • Medical Diagnostics

Background:

  • Current post-ST-segment elevation myocardial infarction (STEMI) left ventricular (LV) remodelling definitions focus solely on structural changes (dilatation).
  • LV function, specifically ejection fraction (EF), is a known predictor of long-term outcomes post-STEMI.
  • Integrating functional parameters into remodelling classification may enhance prognostic accuracy.

Purpose of the Study:

  • To reclassify LV remodelling after STEMI by incorporating both LV dilatation and LVEF.
  • To investigate the prognostic implications of this integrated functional LV remodelling classification.
  • To assess if functional remodelling improves risk stratification beyond structural changes alone.

Main Methods:

  • Retrospective analysis of STEMI patients treated with primary percutaneous coronary intervention (PCI).
  • Patients were categorized into four subgroups based on LV dilatation and LVEF impairment.
  • Outcomes including mortality and heart failure hospitalization were analyzed over a median follow-up of 76 months.

Main Results:

  • A total of 2346 patients were studied.
  • Patients with both LV remodelling and impaired LVEF exhibited significantly lower survival rates (P < 0.001).
  • Event-free survival rates were also significantly lower in the group with LV dilatation and LVEF impairment (P < 0.001).

Conclusions:

  • A functional LV remodelling classification improves risk stratification compared to structural remodelling alone.
  • Identifying patients with the worst prognosis through functional assessment enables early preventative therapies.
  • This approach offers a more comprehensive understanding of post-STEMI cardiac changes and patient outcomes.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
65
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
103
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
54
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
92
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K